189 related articles for article (PubMed ID: 17322931)
21. Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia.
Champlin R
Exp Hematol; 1995 Oct; 23(11):1148-51. PubMed ID: 7556522
[No Abstract] [Full Text] [Related]
22. [Graft-versus-leukemia effect (GVL effect): pathophysiological and clinical aspects].
Nakamura H
Nihon Rinsho; 1990 Sep; 48(9):1977-82. PubMed ID: 2232200
[No Abstract] [Full Text] [Related]
23. The graft-versus-leukaemia effect after allogeneic bone-marrow transplantation: assessment through competing risks approaches.
Katsahian S; Porcher R; Mary JY; Chevret S
Stat Med; 2004 Dec; 23(24):3851-63. PubMed ID: 15580602
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Rowe JM
Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
[TBL] [Abstract][Full Text] [Related]
25. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.
Zheng H; Matte-Martone C; Li H; Anderson BE; Venketesan S; Sheng Tan H; Jain D; McNiff J; Shlomchik WD
Blood; 2008 Feb; 111(4):2476-84. PubMed ID: 18045967
[TBL] [Abstract][Full Text] [Related]
26. Donor leukocyte infusions in myeloid malignancies: new strategies.
Porter DL; Antin JH
Best Pract Res Clin Haematol; 2006; 19(4):737-55. PubMed ID: 16997180
[TBL] [Abstract][Full Text] [Related]
27. Completely mismatched allogeneic CD3/CD28 cross-linked Th1 memory cells elicit anti-leukemia effects in unconditioned hosts without GVHD toxicity.
Har-Noy M; Zeira M; Weiss L; Slavin S
Leuk Res; 2008 Dec; 32(12):1903-13. PubMed ID: 18565579
[TBL] [Abstract][Full Text] [Related]
28. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
29. The role of T-cells in preventing relapse in chronic myelogenous leukemia.
Butturini A; Gale RP
Bone Marrow Transplant; 1987 Dec; 2(4):351-4. PubMed ID: 3332182
[TBL] [Abstract][Full Text] [Related]
30. Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia.
Parmar S; Fernandez-Vina M; de Lima M
Curr Opin Hematol; 2011 Mar; 18(2):98-104. PubMed ID: 21245756
[TBL] [Abstract][Full Text] [Related]
31. Delayed graft versus leukemia effect after allogeneic peripheral stem cell transplantation in a patient with chronic lymphocytic leukemia.
Gutiérrez A; Solano C; Prósper F; Benet I; Sarsotti E; García-Conde J
Haematologica; 2000 Mar; 85(3):330-2. PubMed ID: 10702833
[No Abstract] [Full Text] [Related]
32. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
33. [Role of NK cell receptor-expressing cells in the regulation of GVHD and GVL].
Tanaka J
Rinsho Ketsueki; 2008 Aug; 49(8):598-606. PubMed ID: 18800608
[No Abstract] [Full Text] [Related]
34. Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.
Huang XJ; Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Shi HX
Bone Marrow Transplant; 2009 Sep; 44(5):309-16. PubMed ID: 19234512
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
37. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
[TBL] [Abstract][Full Text] [Related]
38. Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL).
Appelbaum FR
Leukemia; 1997 May; 11 Suppl 4():S15-7. PubMed ID: 9179275
[TBL] [Abstract][Full Text] [Related]
39. Role of allogeneic transplantation in low-grade lymphoma and chronic lymphocytic leukemia.
Thomson KJ; Mackinnon S
Curr Opin Hematol; 2006 Jul; 13(4):273-9. PubMed ID: 16755225
[TBL] [Abstract][Full Text] [Related]
40. Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL.
Ivanov V; Faucher C; Bilger K; Vey N; Sainty D; Calmels B; Chabannon C; Lafage-Pochitaloff M; Mozziconacci MJ; Mohty M; Chrestian MA; Blaise D
Bone Marrow Transplant; 2003 Nov; 32(9):961-3. PubMed ID: 14562000
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
